HomeCompareAVDL vs EQR

AVDL vs EQR: Dividend Comparison 2026

AVDL yields 9.24% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $10.9K in total portfolio value· pulled ahead in Year 6
10 years
AVDL
AVDL
● Live price
9.24%
Share price
$21.64
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36.9K
Annual income
$1,654.52
Full AVDL calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — AVDL vs EQR

📍 EQR pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVDLEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVDL + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVDL pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVDL
Annual income on $10K today (after 15% tax)
$785.58/yr
After 10yr DRIP, annual income (after tax)
$1,406.34/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $3,247.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVDL + EQR for your $10,000?

AVDL: 50%EQR: 50%
100% EQR50/50100% AVDL
Portfolio after 10yr
$42.3K
Annual income
$3,565.06/yr
Blended yield
8.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

AVDL
Analyst Ratings
8
Buy
6
Hold
Consensus: Buy
Price Target
$20.20
-6.7% upside vs current
Range: $18.50 — $22.50
Altman Z
9.1
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVDL buys
0
EQR buys
0
No recent congressional trades found for AVDL or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVDLEQR
Forward yield9.24%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$36.9K$47.8K
Annual income after 10y$1,654.52$5,475.61
Total dividends collected$12.9K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$20.20$70.35

Year-by-year: AVDL vs EQR ($10,000, DRIP)

YearAVDL PortfolioAVDL Income/yrEQR PortfolioEQR Income/yrGap
1$11,624$924.21$11,380$679.82+$244.00AVDL
2$13,442$1,004.04$13,014$837.25+$428.00AVDL
3$15,468$1,085.09$14,961$1,036.20+$507.00AVDL
4$17,718$1,166.96$17,297$1,289.22+$421.00AVDL
5$20,207$1,249.24$20,121$1,613.15+$86.00AVDL
6← crossover$22,953$1,331.56$23,561$2,030.84$608.00EQR
7$25,974$1,413.56$27,783$2,573.54$1.8KEQR
8$29,287$1,494.92$33,013$3,284.39$3.7KEQR
9$32,912$1,575.33$39,547$4,223.51$6.6KEQR
10$36,870$1,654.52$47,791$5,475.61$10.9KEQR

AVDL vs EQR: Complete Analysis 2026

AVDLStock

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Full AVDL Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this AVDL vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVDL vs SCHDAVDL vs JEPIAVDL vs OAVDL vs KOAVDL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.